Skip to main content
SpringerLink
Log in

Chronic obstructive pulmonary disease and inflammatory biomarkers in retired workers exposed to inorganic dusts

  • Research article
  • Published:
Toxicology and Environmental Health Sciences Aims and scope Submit manuscript

Abstract

The persistent lung inflammation results in inhaled toxic dusts bring pathologic changes in airway system that lead to development of chronic obstructive pulmonary disease (COPD). Recently, beyond local inflammation in lung, COPD is regarded as chronic systemic inflammatory disease linked to extra pulmonary disease. Therefore, several local and systemic inflammatory biomarkers were needed to be investigated for understanding of COPD. Hence, this current study was aimed to identify the association between COPD and inflammatory biomarkers in workers exposed to inorganic dusts. Clara cell secretary proteins (CC-16) and surfactant protein D (SP-D) were chosen as local inflammatory biomarker, high sensitive Creactive protein (hsCRP), interleukin (IL)-6, serum amyloid protein A (SAA) and tyrosine lysine leucine 40 (YKL-40) were chosen as systemic inflammatory markers in 39 COPD and 39 control group. In current study, CC-16, hsCRP and YKL-40 were linked to COPD in conditional logistic regression model. Furthermore, CC-16 and hsCRP are related to COPD independently to working duration and smoking history. These results suggest that local and inflammatory biomarker could be independent predictor of COPD in worker exposed to inorganic dusts.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Hnizdo, E. & Vallyathan, V. Chronic obstructive pulmonary disease due to occupational exposure to silica dust: a review of epidemiological and pathological evidence. Occup. Environ. Med. 60, 237–243 (2003).

    Article  PubMed  CAS  Google Scholar 

  2. Bergdahl, I. A. et al. Increased mortality in COPD among construction workers exposed to inorganic dust. Eur. Respir. J. 23, 402–406 (2004).

    Article  PubMed  CAS  Google Scholar 

  3. Rabe, K. F. et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am. J. Respir. Crit. Care Med. 176, 532–555 (2007).

    Article  PubMed  Google Scholar 

  4. van Eeden, S. F. & Sin, D. D. Chronic obstructive pul-Chronic Obstructive Pulmonary Disease and Inflammatory Biomarkers 89 monary disease: a chronic systemic inflammatory disease. Respiration 75, 224–238 (2008).

    Google Scholar 

  5. Jones, P. W. & Agusti, A. G. Outcomes and markers in the assessment of chronic obstructive pulmonary disease. Eur. Respir. J. 27, 822–832 (2006).

    Article  PubMed  CAS  Google Scholar 

  6. Kelly, E., Owen, C. A., Pinto-Plata, V. & Celli, B. R. The role of systemic inflammatory biomarkers to predict mortality in chronic obstructive pulmonary disease. Expert Rev. Respir. Med. 7, 57–64 (2013).

    Article  PubMed  CAS  Google Scholar 

  7. Braido, F. et al. Clara cell 16 protein in COPD sputum: a marker of small airways damage? Respir. Med. 101, 2119–2124 (2007).

    Article  PubMed  Google Scholar 

  8. Lomas, D. A. et al. Evaluation of serum CC-16 as a biomarker for COPD in the ECLIPSE cohort. Thorax 63, 1058–1063 (2008).

    Article  PubMed  CAS  Google Scholar 

  9. Agusti, A. et al. Persistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotype. PLoS One 7, e37483 (2012).

    Article  PubMed  CAS  Google Scholar 

  10. He, J. Q. et al. Associations of IL6 polymorphisms with lung function decline and COPD. Thorax 64, 698–704 (2009).

    Google Scholar 

  11. Nillawar, A. N., Bardapurkar, J. S. & Bardapurkar, S. J. High sensitive C-reactive protein as a systemic inflammatory marker and LDH-3 isoenzyme in chronic obstructive pulmonary disease. Lung India 29, 24–29 (2012).

    Google Scholar 

  12. Korfhagen, T. R. et al. Surfactant protein-D regulates surfactant phospholipid homeostasis in vivo. J. Biol. Chem. 273, 28438–28443 (1998).

    Article  PubMed  CAS  Google Scholar 

  13. Barnes, P. J. et al. Pulmonary biomarkers in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 174, 6–14 (2006).

    Article  PubMed  CAS  Google Scholar 

  14. Stockley, R. A. Biomarkers in COPD: time for a deep breath. Thorax 62, 657–660 (2007).

    Article  PubMed  CAS  Google Scholar 

  15. Umland, T. C. et al. Structure of a human Clara cell phospholipid-binding protein-ligand complex at 1.9 A resolution. Nat. Struct. Mol. Biol. 1, 538–545 (1994).

    Article  CAS  Google Scholar 

  16. Yoneda, K. Ultrastructural localization of phospholipases in the Clara cell of the rat bronchiole. Am. J. Pathol. 93, 745–752 (1978).

    PubMed  CAS  Google Scholar 

  17. Van Vyve, T. et al. Protein content in bronchoalveolar lavage fluid of patients with asthma and control subjects. J. Allergy Clin. 95, 60–68 (1995).

    Article  Google Scholar 

  18. Mattsson, J., Remberger, M., Andersson, O., Sundberg, B. & Nord, M. Decreased serum levels of clara cell secretory protein (CC16) are associated with bronchiolitis obliterans and may permit early diagnosis in patients after allogeneic stem-cell transplantation. Transplantation 79, 1411–1416 (2005).

    Google Scholar 

  19. Shijubo, N. et al. Clara cell protein-positive epithelial cells are reduced in small airways of asthmatics. Am. J. Respir. Crit. Care Med. 160, 930–933 (1999).

    Article  PubMed  CAS  Google Scholar 

  20. Bernard, A., Marchandise, F. X., Depelchin, S., Lauwerys, R. & Sibille, Y. Clara cell protein in serum and bronchoalveolar lavage. Eur. Respir. J. 5, 1231–1238 (1992).

    PubMed  CAS  Google Scholar 

  21. Pilette, C. et al. Reduced epithelial expression of secretory component in small airways correlates with airflow obstruction in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 163, 185–194 (2001).

    Article  PubMed  CAS  Google Scholar 

  22. Honda, Y. et al. Pulmonary surfactant protein D in sera and bronchoalveolar lavage fluids. Am. J. Respir. Crit. Care Med. 152, 1860–1866 (1995).

    Article  PubMed  CAS  Google Scholar 

  23. Ohnishi, H. et al. Comparative study of KL-6, surfactant protein-A, surfactant protein-D, and monocyte chemoattractant protein-1 as serum markers for interstitial lung diseases. Am. J. Respir. Crit. Care Med. 165, 378–381 (2002).

    Article  PubMed  Google Scholar 

  24. Lomas, D. A. et al. Serum surfactant protein D is steroid sensitive and associated with exacerbations of COPD. Eur. Respir. J. 34, 95–102 (2009).

    Article  PubMed  CAS  Google Scholar 

  25. Winkler, C. et al. Comprehensive characterisation of pulmonary and serum surfactant protein D in COPD. Respir. Res. 12, 29 (2011).

    Article  PubMed  CAS  Google Scholar 

  26. Yildiz, F., Basyigit, I., Yildirim, E., Boyaci, H. & Ilgazli, A. Does addition of inhaled steroid to combined bronchodilator therapy affect health status in patients with COPD? Respirology 9, 352–355 (2004).

    Article  PubMed  Google Scholar 

  27. Pommer, P. [Peer-reviewed study: COPD — increases risk of pneumonia in early steroid therapy]. Pneumologie 64, 720 (2010).

    Article  PubMed  Google Scholar 

  28. Akl, E. A., Grant, B. J., Guyatt, G. H., Montori, V. M. & Schunemann, H. J. A decision aid for COPD patients considering inhaled steroid therapy: development and before and after pilot testing. BMC medical informatics and decision making 7, 12 (2007).

    Article  PubMed  Google Scholar 

  29. Cano, N. J. et al. C-reactive protein and body mass index predict outcome in end-stage respiratory failure. Chest 126, 540–546 (2004).

    Article  PubMed  Google Scholar 

  30. Dev, D. et al. Value of C-reactive protein measurements in exacerbations of chronic obstructive pulmonary disease. Respir. Med. 92, 664–667 (1998).

    Article  PubMed  CAS  Google Scholar 

  31. Sin, D. D., Lacy, P., York, E. & Man, S. F. Effects of fluticasone on systemic markers of inflammation in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 170, 760–765 (2004).

    Article  PubMed  Google Scholar 

  32. Ridker, P. M. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 107, 363–369 (2003).

    Article  PubMed  Google Scholar 

  33. Hansell, A. L., Walk, J. A. & Soriano, J. B. What do chronic obstructive pulmonary disease patients die from? A multiple cause coding analysis. Eur. Respir. J. 22, 809–814 (2003).

    Article  PubMed  CAS  Google Scholar 

  34. Broekhuizen, R., Wouters, E. F., Creutzberg, E. C. & Schols, A. M. Raised CRP levels mark metabolic and functional impairment in advanced COPD. Thorax 61, 17–22 (2006).

    Article  PubMed  CAS  Google Scholar 

  35. Bozinovski, S. et al. Serum amyloid a is a biomarker of acute exacerbations of chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 177, 269–278 (2008).

    Article  PubMed  CAS  Google Scholar 

  36. Sapey, E. & Stockley, R. A. COPD exacerbations. 2: aetiology. Thorax 61, 250–258 (2006).

    Article  PubMed  CAS  Google Scholar 

  37. Boot, R. G. et al. Strong induction of members of the chitinase family of proteins in atherosclerosis: chito-triosidase and human cartilage gp-39 expressed in lesion macrophages. Arterioscle. Thromb. Vasc. Biol. 19, 687–694 (1999).

    Article  CAS  Google Scholar 

  38. Chupp, G. L. et al. A chitinase-like protein in the lung and circulation of patients with severe asthma. N. Engl. J. Med. 357, 2016–2027 (2007).

    Article  PubMed  CAS  Google Scholar 

  39. Yoon, J.-H. et al. Association between impaired lung function and coronary artery calcium score in workers exposed to inorganic dust. Toxicol. Environ. Health Sci. 4, 139–142 (2012).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Occupational Lung Diseases Institute, 87, Guryong-ro, Sangnokgu, Ansan-si, Gyeonggi-do, 426-858, Korea

    Joo Hwan Hwang, Jin-Ha Yoon, JaeHoon Shin, Byung-Soon Choi, You Lim Lee & Jong Sung Lee

  2. Forensic DNA Center, National Forensic Service, 139, Jiyang-ro, Yangcheon-gu, Seoul, Korea

    Kyung Myung Lee

Authors
  1. Joo Hwan Hwang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jin-Ha Yoon
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. JaeHoon Shin
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Byung-Soon Choi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. You Lim Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Jong Sung Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Kyung Myung Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Joo Hwan Hwang.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hwang, J.H., Yoon, JH., Shin, J. et al. Chronic obstructive pulmonary disease and inflammatory biomarkers in retired workers exposed to inorganic dusts. Toxicol. Environ. Health Sci. 5, 86–91 (2013). https://doi.org/10.1007/s13530-013-0162-9

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13530-013-0162-9

Keywords

Search

Navigation